Social Media Ideas for Anaphylm (Aqst-109)

Latest updates for Anaphylm (Aqst-109)

Fresh curated links around Anaphylm (AQST-109) are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Post angles to try

Share the most useful takeaway for your audience.

Turn one article into a quick practical checklist.

Ask your audience how this shift affects their work.

Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

snacksafely.com /1 month ago

Aquestive Resubmits Needle-Free Sublingual Epinephrine to FDA for Approval

Aquestive resubmits its Anaphylm NDA after completing additional human factors and pharmacokinetic studies requested by the FDA. The post Aquestive Resubmits Needle-Free Sublingual...

Read source

snacksafely.com /1 week ago

FDA Accepts Anaphylm Epinephrine Resubmission, Sets March 2027 Decision Date

The FDA accepts Anaphylm's resubmitted application, setting a March 2027 decision date for the needle-free epinephrine treatment. The post FDA Accepts Anaphylm Epinephrine Resubmis...

Read source

snacksafely.com /1 month ago

Coming Soon: The Next Generation of Needle-Free Epinephrine Options

A new generation of needle-free emergency epinephrine products will soon give patients many more options. The post Coming Soon: The Next Generation of Needle-Free Epinephrine Optio...

Read source

cafepharma.com /3 weeks ago

Allergy Territory Account Specialist

Allergy Territory Account Specialist Anonymous (not verified) Tue, 09/29/2026 - 01:04 field_thread_url https://cafepharma.com/boards/threads/allergy-territ...

Read source

cafepharma.com /1 month ago

Allergy Territory Account Specialist

Allergy Territory Account Specialist Anonymous (not verified) Sun, 09/20/2026 - 21:56 field_thread_url https://cafepharma.com/boards/threads/allergy-territ...

Read source

healio.com /2 days ago

Tezepelumab sustains EoE remission, dysphagia relief at 52 weeks

NASHVILLE, Tenn. — Tezepelumab significantly improved histologic remission and dysphagia symptoms at 24 and 52 weeks compared with placebo among individuals with eosinophilic esoph...

Read source

snacksafely.com /1 week ago

Novartis Launches Phase III Trial of Pill That Could Help Protect Against Reactions

Novartis is testing an experimental pill that could help protect people with food allergies from accidental exposure. The post Novartis Launches Phase III Trial of Pill That Could...

Read source

snacksafely.com /2 weeks ago

Another Needle-Free Epinephrine Option Moves Closer to FDA Review

Belhaven launches pivotal trial of Nasdepi, a needle-free epinephrine nasal powder designed to treat life-threatening allergic reactions. The post Another Needle-Free Epinephrine O...

Read source

medcitynews.com /1 month ago

AstraZeneca, Amgen Drug Moves Closer to Competing With Dupixent in a New Indication

AstraZeneca and Amgen drug Tezspire met the goals of a Phase 3 test in eosinophilic esophagitis (EoE), a chronic disorder whose only approved biologic therapy is Sanofi’s Dupixent....

Read source

healthywomen.org /1 month ago

Biologics for Treating Asthma

Asthma is one of most common diseases in the United States, affecting around 11 in 100 women. It’s a chronic (long-lasting) condition that causes swelling in your airway, making it...

Read source

webwire.com /1 month ago

Tezspire demonstrates positive Phase III results in eosinophilic esophagitis across both co-primary and all key secondar...

Positive high-level results from the Phase III CROSSING trial in patients with eosinophilic esophagitis (EoE) showed that AstraZeneca and Amgen's Tezspire (tezepelumab) demonstrate...

Read source

medinform.jmir.org /1 day ago

Screening for Cough Variant Asthma Using the TabPFN Model on Routine Laboratory Data in a Multicenter Cohort: Prospectiv...

Background: Cough variant asthma (CVA) is a prevalent but underdiagnosed subtype of chronic cough, largely due to the limited accessibility of pulmonary function tests in primary c...

Read source

healthywomen.org /1 month ago

Asthma 101

Imagine breathing through a straw. Now imagine you’re running or very stressed and trying to breathe through that straw. This is what millions of people with asthma experience when...

Read source

moneytalksnews.com /1 month ago

Epinephrine Injections Recalled: See List of Affected Products

Three recalled lots may contain glass and other particles, so check the vial details before using emergency medication intended for severe allergic reactions

Read source

kevinmd.com /1 month ago

Epinephrine on airplanes should not depend on the airline

“Is there a doctor or medical professional on board?” Answer that call and you may be treating anaphylaxis in a cramped cabin, mid-turbulence, with no medical history, no weight, n...

Read source

snacksafely.com /3 weeks ago

Australia Restricts Herbal Supplement Over Anaphylaxis Risk While It Remains Available in US

Australia is removing Andrographis medicines over anaphylaxis concerns while the herbal ingredient remains widely available in US dietary supplements. The post Australia Restricts...

Read source

snacksafely.com /1 month ago

Rare Antibodies Could Lead to First Targeted Treatment for Alpha-Gal Syndrome

NIH researchers discovered rare antibodies that could potentially block allergic reactions in people with alpha-gal syndrome. The post Rare Antibodies Could Lead to First Targeted...

Read source

cafepharma.com /5 days ago

Argenx

Argenx Anonymous (not verified) Mon, 10/19/2026 - 10:14 field_thread_url https://cafepharma.com/boards/threads/argenx.665212/ board name...

Read source

planetayurveda.com /3 weeks ago

Shwasakasachintamani Ras

Shwasakasachintamani Ras – Ingredients, Preparation, Ayurvedic Properties, Indications & Dosages Abstract In the realm of Ayurvedic pathology, Shwasa (dyspnea/asthma) and ... R...

Read source

cafepharma.com /2 weeks ago

Airsupradupra

Airsupradupra Anonymous (not verified) Wed, 10/07/2026 - 04:08 field_thread_url https://cafepharma.com/boards/threads/airsupradupra.691730/...

Read source

snacksafely.com /3 weeks ago

Study Finds Eczema Drug Dupilumab Drives Down Food Allergy IgE but Increases Reactions

Dupilumab dramatically lowers food-specific IgE, but new research finds those declines may not signal increased food tolerance. The post Study Finds Eczema Drug Dupilumab Drives Do...

Read source

biopharmadive.com /1 month ago

Celldex sinks as safety concerns cloud immune drug results

Though barzolvolimab displayed what one analyst described as the best efficacy results to date against chronic skin hives, treatment was also associated with two life-threatening a...

Read source

drugs.com /1 month ago

Semaglutide Linked To 40% Fewer Asthma Attacks

WEDNESDAY, Sept. 9, 2026 — A widely used weight-loss and diabetes drug may offer a surprising bonus: healthier lungs."GLP-1 receptor agonists are widely used to treat type 2 diabe...

Read source

snacksafely.com /1 month ago

Sempresto’s Award-Winning Epinephrine Auto-Injector Tackles a Major Problem: Remembering to Carry It

Sempresto’s award-winning concept attaches an epinephrine auto-injector to a smartphone, aiming to keep life-saving medication within reach. The post Sempresto’s Award-Winning Epin...

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.